NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | - | - | - |
What is the latest Capital Work in Progress ratio of NATH BIOGENES (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2013 | - |
How is Capital Work in Progress of NATH BIOGENES (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2013 | - | - | |
Compare Capital Work in Progress of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹306.2 Cr | -6% | -6.5% | 1.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,624.9 Cr | -1.4% | 5.9% | -13% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,730.6 Cr | -5.6% | 0.7% | -31.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,278.2 Cr | -3.1% | 6.9% | 2.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹995.9 Cr | -1.6% | -4.3% | -25.2% | Stock Analytics | |
| INDO US BIOTECH | ₹210.6 Cr | -5.8% | -1.5% | -29.5% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -6% |
-6.5% |
1.8% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses